Gene expression signatures, pathways and networks in carotid atherosclerosis

Journal of Internal Medicine

Volumn 279, Issue 3, 2016, Pages 293-308

  Perisic, Ljubica ^a   Aldi, S ^a   Sun, Y ^b   Folkersen, L ^c,d   Razuvaev, A ^a   Roy, J ^a   Lengquist, M ^a   Akesson S ^a   Wheelock, C E ^d   Maegdefessel, L ^d   Gabrielsen, A ^d   Odeberg, J ^d,e   Hansson, G K ^d   Paulsson Berne, G ^d   Hedin, Ulf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c NOVO NORDISK A S   (Denmark)

^d KAROLINSKA INSTITUTE   (Sweden)

^e ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Atherosclerosis; Carotid plaques; Gene expression; Microarrays

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 26A1; CYTOCHROME P450 2B6; GELATINASE B; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LMOD1 PROTEIN; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MALAT1 PROTEIN; MIR155HG PROTEIN; NITRIC OXIDE; PLIN2 PROTEIN; PROTEIN; SYNPO2 PROTEIN; TP53TG PROTEIN; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ACTIN FILAMENT; ADULT; AGED; ANGIOGENESIS; ANTIGEN RETRIEVAL; APOPTOSIS; ARTICLE; BLOOD; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE REGULATORY NETWORK; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OSTEOBLAST; OSTEOLYSIS; PHENOTYPE; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION; UPREGULATION; CAROTID ARTERY DISEASE; GENETICS; SIGNAL TRANSDUCTION;

AGED; CAROTID ARTERY DISEASES; FEMALE; GENE REGULATORY NETWORKS; HUMANS; MALE; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84958933712     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12448     Document Type: Article

References (71)

1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-25.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
3. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists C. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-24.
4. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6: 1063-72.
5. Rothwell PM. Prediction and prevention of stroke in patients with symptomatic carotid stenosis: the high-risk period and the high-risk patient. Eur J Vasc Endovasc Surg 2008; 35: 255-63.
6. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006; 113: 2320-8.
7. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001; 103: 926-33.
8. Kunte H, Amberger N, Busch MA, Ruckert RI, Meiners S, Harms L. Markers of instability in high-risk carotid plaques are reduced by statins. J Vasc Surg 2008; 47: 513-22.
9. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000; 405: 827-36.
10. Hiltunen MO, Tuomisto TT, Niemi M et al. Changes in gene expression in atherosclerotic plaques analyzed using DNA array. Atherosclerosis 2002; 165: 23-32.
11. Ijas P, Nuotio K, Saksi J et al. Microarray analysis reveals overexpression of CD163 and HO-1 in symptomatic carotid plaques. Arterioscler Thromb Vasc Biol 2007; 27: 154-60.
12. Randi AM, Biguzzi E, Falciani F et al. Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis. J Thromb Haemost 2003; 1: 829-35.
13. Woodside KJ, Hernandez A, Smith FW et al. Differential gene expression in primary and recurrent carotid stenosis. Biochem Biophys Res Commun 2003; 302: 509-14.
14. Saksi J, Ijas P, Nuotio K et al. Gene expression differences between stroke-associated and asymptomatic carotid plaques. J Mol Med 2011; 89: 1015-26.
15. Sluimer JC, Kisters N, Cleutjens KB et al. Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery. Physiol Genomics 2007; 30: 335-41.
16. Folkersen L, Persson J, Ekstrand J et al. Prediction of ischemic events on the basis of transcriptomic and genomic profiling in patients undergoing carotid endarterectomy. Mol Med 2012; 18: 669-75.
17. Miller CL, Haas U, Diaz R et al. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet 2014; 10: e1004263.
18. Kojima Y, Downing K, Kundu R et al. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Investig 2014; 124: 1083-97.
19. Smedbakken LM, Halvorsen B, Daissormont I et al. Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization. Atherosclerosis 2012; 224: 266-73.
20. Salagianni M, Galani IE, Lundberg AM et al. Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. Circulation 2012; 126: 952-62.
21. Perisic L, Hedin E, Razuvaev A et al. Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33: 2432-43.
22. Wang J, Razuvaev A, Folkersen L et al. The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation. Atherosclerosis 2012; 220: 102-9.
23. Razuvaev A, Ekstrand J, Folkersen L et al. Correlations between clinical variables and gene-expression profiles in carotid plaque instability. Eur J Vasc Endovasc Surg 2011; 42: 722-30.
24. Agardh HE, Folkersen L, Ekstrand J et al. Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med 2011; 269: 200-10.
25. Gertow K, Nobili E, Folkersen L et al. 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis 2011; 215: 411-6.
26. Gistera A, Robertson AK, Andersson J et al. Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci Transl Med 2013; 5: 196ra00.
27. Gabrielsen A, Qiu H, Back M et al. Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion. J Mol Med 2010; 88: 795-806.
28. Olofsson PS, Soderstrom LA, Jern C et al. Genetic variants of TNFSF4 and risk for carotid artery disease and stroke. J Mol Med 2009; 87: 337-46.
29. Osterholm C, Folkersen L, Lengquist M et al. Increased expression of heparanase in symptomatic carotid atherosclerosis. Atherosclerosis 2013; 226: 67-73.
30. Ovchinnikova OA, Folkersen L, Persson J et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. J Intern Med 2014; 276: 525-36.
31. Persson J, Folkersen L, Ekstrand J et al. High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis. Atherosclerosis 2012; 225: 491-6.
32. Rothwell PM, Pendlebury ST, Wardlaw J, Warlow CP. Critical appraisal of the design and reporting of studies of imaging and measurement of carotid stenosis. Stroke 2000; 31: 1444-50.
33. Halliday A, Harrison M, Hayter E et al. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet 2010; 376: 1074-84.
34. Lesack K, Naugler C. An open-source software program for performing Bonferroni and related corrections for multiple comparisons. J Pathol Inform 2011; 2: 52.
35. Glaab E, Garibaldi JM, Krasnogor N. ArrayMining: a modular web-application for microarray analysis combining ensemble and consensus methods with cross-study normalization. BMC Bioinformatics 2009; 10: 358.
36. Xia J, Fjell CD, Mayer ML, Pena OM, Wishart DS, Hancock RE. INMEX-a web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res 2013; 41: W63-70.
37. Wu J, Vallenius T, Ovaska K, Westermarck J, Makela TP, Hautaniemi S. Integrated network analysis platform for protein-protein interactions. Nat Methods 2009; 6: 75-7.
38. Cowley MJ, Pinese M, Kassahn KS et al. PINA v2.0: mining interactome modules. Nucleic Acids Res 2012; 40: D862-5.
39. Le Cao KA, Boitard S, Besse P. Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems. BMC Bioinformatics 2011; 12: 253.
40. Papaspyridonos M, Smith A, Burnand KG et al. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006; 26: 1837-44.
41. Rothwell PM. ACST: which subgroups will benefit most from carotid endarterectomy? Lancet 2004; 364: 1122-3; author reply 5-6.
42. Tripathi V, Ellis JD, Shen Z et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 2010; 39: 925-38.
43. Michalik KM, You X, Manavski Y et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 2014; 114: 1389-97.
44. Ren S, Peng Z, Mao JH et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 2012; 22: 806-21.
45. Takei Y, Ishikawa S, Tokino T, Muto T, Nakamura Y. Isolation of a novel TP53 target gene from a colon cancer cell line carrying a highly regulated wild-type TP53 expression system. Genes Chromosom Cancer 1998; 23: 1-9.
46. Salem MK, Vijaynagar B, Sayers RD et al. Histologically unstable asymptomatic carotid plaques have altered expression of genes involved in chemokine signalling leading to localised plaque inflammation and rupture. Eur J Vasc Endovasc Surg 2013; 45: 121-7.
47. Song BL, Sever N, DeBose-Boyd RA. Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol Cell 2005; 19: 829-40.
48. Farmer JA. Pleiotropic effects of statins. Curr Atheroscler Rep 2000; 2: 208-17.
49. Kwee RM. Systematic review on the association between calcification in carotid plaques and clinical ischemic symptoms. J Vasc Surg 2010; 51: 1015-25.
50. Saremi A, Bahn G, Reaven PD, Investigators V. Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care 2012; 35: 2390-2.
51. Grasser WA, Baumann AP, Petras SF et al. Regulation of osteoclast differentiation by statins. J Musculoskelet Neuronal Interact 2003; 3: 53-62.
52. Tintut Y, Morony S, Demer LL. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 2004; 24: e6-10.
53. Peeters W, Hellings WE, de Kleijn DP et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol 2009; 29: 128-33.
54. Kostek MA, Angelopoulos TJ, Clarkson PM et al. Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity. Med Sci Sports Exerc 2009; 41: 1063-71.
55. Levy AP, Moreno PR. Intraplaque hemorrhage. Curr Mol Med 2006; 6: 479-88.
56. Ijas P, Saksi J, Soinne L et al. Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. Atherosclerosis 2013; 230: 228-34.
57. Degraba TJ, Hoehn GT, Nyquist PA et al. Biomarker discovery in serum from patients with carotid atherosclerosis. Cerebrovasc Dis Extra 2011; 1: 115-29.
58. Wingrove JA, Daniels SE, Sehnert AJ et al. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ Cardiovasc Genet 2008; 1: 31-8.
59. Ridker PM, Howard CP, Walter V et al. Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation 2012; 126: 2739-48.
60. Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJ, Meldrum H; North American Symptomatic Carotid Endarterectomy Trial C. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 2001; 345: 1084-90.
61. McCarthy MJ, Loftus IM, Thompson MM et al. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 1999; 30: 261-8.
62. Freson K, De Vos R, Wittevrongel C et al. The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure. Blood 2005; 106: 2356-62.
63. Howard DP, van Lammeren GW, Redgrave JN et al. Histological features of carotid plaque in patients with ocular ischemia versus cerebral events. Stroke 2013; 44: 734-9.
64. Nelander S, Mostad P, Lindahl P. Prediction of cell type-specific gene modules: identification and initial characterization of a core set of smooth muscle-specific genes. Genome Res 2003; 13: 1838-54.
65. Nanda V, Miano JM. Leiomodin 1, a new serum response factor-dependent target gene expressed preferentially in differentiated smooth muscle cells. J Biol Chem 2012; 287: 2459-67.
66. Schroeter MM, Beall B, Heid HW, Chalovich JM. In vitro characterization of native mammalian smooth-muscle protein synaptopodin 2. Biosci Rep 2008; 28: 195-203.
67. Gleissner CA, von Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 2008; 28: 1920-7.
68. Martinez-Botas J, Anderson JB, Tessier D et al. Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet 2000; 26: 474-9.
69. Tansey JT, Sztalryd C, Gruia-Gray J et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 2001; 98: 6494-9.
70. Lovett JK, Redgrave JN, Rothwell PM. A critical appraisal of the performance, reporting, and interpretation of studies comparing carotid plaque imaging with histology. Stroke 2005; 36: 1091-7.
71. Turpeinen H, Raitoharju E, Oksanen A et al. Proprotein convertases in human atherosclerotic plaques: the overexpression of FURIN and its substrate cytokines BAFF and APRIL. Atherosclerosis 2011; 219: 799-806.